Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP651716.RAJro2YSUfaxNkHwZG7bodOjMNukmk-MRZoUv0NpmvsPM130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP651716.RAJro2YSUfaxNkHwZG7bodOjMNukmk-MRZoUv0NpmvsPM130_assertion type Assertion NP651716.RAJro2YSUfaxNkHwZG7bodOjMNukmk-MRZoUv0NpmvsPM130_head.
- NP651716.RAJro2YSUfaxNkHwZG7bodOjMNukmk-MRZoUv0NpmvsPM130_assertion description "[Given the paucity of data in type 1 diabetes concerning lipoprotein-associated phospholipase A( 2) (Lp-PLA(2)), we examined its prospective relationship with coronary artery disease (CAD), as well as the effect of modification by C-reactive protein (CRP) and haptoglobin genotype, in individuals with type 1 diabetes who are at an increased risk for CAD due to also having macroalbuminuria (n=96).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP651716.RAJro2YSUfaxNkHwZG7bodOjMNukmk-MRZoUv0NpmvsPM130_provenance.
- NP651716.RAJro2YSUfaxNkHwZG7bodOjMNukmk-MRZoUv0NpmvsPM130_assertion evidence source_evidence_literature NP651716.RAJro2YSUfaxNkHwZG7bodOjMNukmk-MRZoUv0NpmvsPM130_provenance.
- NP651716.RAJro2YSUfaxNkHwZG7bodOjMNukmk-MRZoUv0NpmvsPM130_assertion SIO_000772 20368232 NP651716.RAJro2YSUfaxNkHwZG7bodOjMNukmk-MRZoUv0NpmvsPM130_provenance.
- NP651716.RAJro2YSUfaxNkHwZG7bodOjMNukmk-MRZoUv0NpmvsPM130_assertion wasDerivedFrom befree-20140225 NP651716.RAJro2YSUfaxNkHwZG7bodOjMNukmk-MRZoUv0NpmvsPM130_provenance.
- NP651716.RAJro2YSUfaxNkHwZG7bodOjMNukmk-MRZoUv0NpmvsPM130_assertion wasGeneratedBy ECO_0000203 NP651716.RAJro2YSUfaxNkHwZG7bodOjMNukmk-MRZoUv0NpmvsPM130_provenance.